Literature DB >> 15368593

Generalized Anxiety Disorder and major depressive disorder comorbidity in the National Survey of Mental Health and Well-Being.

Caroline Hunt1, Tim Slade, Gavin Andrews.   

Abstract

We report population data on DSM-IV Generalized Anxiety Disorder (GAD) from the Australian National Survey of Mental Health and Well-Being, obtained from a nationwide household survey of adults using a stratified multistage sampling process. A response rate of 78.1% resulted in 10,641 persons being interviewed. Diagnoses were made using the Composite International Diagnostic Interview. The interview was computerised and conducted by trained lay interviewers. We investigated comorbidity between GAD and major depressive disorder (MDD). The results indicate that sociodemographic correlates of GAD, and associated disablement and service use, are influenced by the presence of a comorbid depressive disorder but cannot be fully explained by the presence of that disorder. In addition, GAD was confirmed as significantly disabling, even as a single disorder. We conclude that the results are consistent with the view that GAD has a significant and independent impact on the burden of mental disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15368593     DOI: 10.1002/da.20019

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  16 in total

1.  Temporal patterns of anxious and depressed mood in generalized anxiety disorder: a daily diary study.

Authors:  Lisa R Starr; Joanne Davila
Journal:  Behav Res Ther       Date:  2011-12-07

2.  Epilepsy and parent stress: the chicken and the egg dilemma.

Authors:  Rochelle Caplan
Journal:  Epilepsy Curr       Date:  2015 Jan-Feb       Impact factor: 7.500

Review 3.  Pregabalin: a review of its use in adults with generalized anxiety disorder.

Authors:  James E Frampton
Journal:  CNS Drugs       Date:  2014-09       Impact factor: 5.749

4.  Prevalence of depression, anxiety and associated factors among school going adolescents in Bangladesh: Findings from a cross-sectional study.

Authors:  Md Saiful Islam; Md Estiar Rahman; Mst Sabrina Moonajilin; Jim van Os
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

5.  Investigating the separate and interactive associations of trauma and depression on brain structure: implications for cognition and aging.

Authors:  Aimee J Karstens; Olusola Ajilore; Leah H Rubin; Shaolin Yang; Aifeng Zhang; Alex Leow; Anand Kumar; Melissa Lamar
Journal:  Int J Geriatr Psychiatry       Date:  2017-06-23       Impact factor: 3.485

6.  "Caseness" for depression and anxiety in a depressed outpatient population: symptomatic outcome as a function of baseline diagnostic categories.

Authors:  Koen Demyttenaere; Anne Verhaeghen; Nicolas Dantchev; Luigi Grassi; Angel L Montejo; David G S Perahia; Deborah Quail; Catherine Reed; Andre Tylee; Michael Bauer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

7.  Characterization of Disability in Canadians with Mental Disorders Using an Abbreviated Version of a DSM-5 Emerging Measure: The 12-Item WHO Disability Assessment Schedule (WHODAS) 2.0.

Authors:  Kirsten Sjonnesen; Andrew G M Bulloch; Jeanne Williams; Dina Lavorato; Scott B Patten
Journal:  Can J Psychiatry       Date:  2016-02-16       Impact factor: 4.356

8.  Correlates of generalized anxiety disorder: independent of co-morbidity with depression: findings from the first Israeli National Health Interview Survey (2003-2004).

Authors:  Khitam Muhsen; Joshua Lipsitz; Noga Garty-Sandalon; Raz Gross; Manfred S Green
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-19       Impact factor: 4.328

9.  Gray matter structures associated with neuroticism: A meta-analysis of whole-brain voxel-based morphometry studies.

Authors:  Xiqin Liu; Han Lai; Jingguang Li; Benjamin Becker; Yajun Zhao; Bochao Cheng; Song Wang
Journal:  Hum Brain Mapp       Date:  2021-03-11       Impact factor: 5.038

Review 10.  Assessing the utility of intermediate phenotypes for genetic mapping of psychiatric disease.

Authors:  Jonathan Flint; Nicholas Timpson; Marcus Munafò
Journal:  Trends Neurosci       Date:  2014-09-09       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.